Since NF-κB and related factors can activate and regulate key molecules related to inflammation in cancer, substantial research is ongoing to assess the potential of NF-κB and related proteins as potential therapeutic targets in some cancers (Li & Verma, 2002). This evidence concerns the gene NFKB1 and cancer.